HealthCare Products

World Top 100 HealthCare Products Companies List by Market Cap in July 2023

World Top 100 HealthCare Products Companies List by Market Cap in July-30-2023, World Biggest 100 HealthCare Products Companies by Market Cap, World Largest 100 HealthCare Products Companies in the World by market cap as on July-30-2023.

Metatag Title
World Largest 500 HealthCare Products Companies in 2023
Metatag Abstract
World Top 500 HealthCare Products Companies by Market Cap in 2023, World Largest 500 HealthCare Products Companies by Market Cap in 2023.
Metatag Description
World Top 500 HealthCare Products Companies by Market Cap in 2023, World Largest 500 HealthCare Products Companies by Market Cap in 2023.
Metatag Keywords
World Top 500 HealthCare Products Companies by Market Cap in 2023, World Largest 500 HealthCare Products Companies by Market Cap in 2023.

  1. Unitedhealth Group

    World Rank (Jul-30-2023)
    12
    Market Cap (Jul-30-2023)
    468.230 Billion USD
    World Rank (Dec-25-2022)
    7
    Market Cap (Dec-25-2022)
    496.430 Billion USD
    World Rank (Jan-07-2022)
    16
    Market Cap (Jan-07-2022)
    431.93 Billion USD
    World Rank (Jan-01-2021)
    21
    Market Cap (Jan-01-2021)
    332.73 Billion USD
    Employee Count
    380,000
    Employee Count as of Date
    As on Dec-2022
    Total Assets in USD
    245,700 Million USD
    Total Liabilities in USD
    159,360 Million USD
    Balance Sheet for Period Ending
    Dec-2022 ending year
    Annual Revenue in USD
    322,130 Million USD
    Annual Operating Income in USD
    26,400 Million USD
    Annual Net Income in USD
    20,120.00 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    CEO
    Andrew Witty
    Stock Exchange LC
    NYSE
    Stock Category LC
    Dow Jones Index (DJIA)
    S&P 500
    Wikipedia
    Yahoo @ NYSE
    Company Profile

    UnitedHealth Group is a health and well-being company headquartered in the United States, and helping people live healthier lives and helping make the health system work better for everyone. Headquarters is in USA.

    Facts About Company
    • UnitedHealth Group annual revenue generated for period ending Dec-2022 was 322.13 Billion USD.
    • UnitedHealth Group annual net income generated for period ending Dec-2022 was 20.12 Billion USD.
    • UnitedHealth Group annual revenue generated for period ending Dec-2021 was 285.27 Billion USD.
    • UnitedHealth Group annual net income generated for period ending Dec-2021 was 17.28 Billion USD.

  2. Johnson & Johnson

    World Rank (Jul-30-2023)
    15
    Market Cap (Jul-30-2023)
    453.430 Billion USD
    World Rank (Dec-25-2022)
    8
    Market Cap (Dec-25-2022)
    464.020 Billion USD
    World Rank (Jan-07-2022)
    14
    Market Cap (Jan-07-2022)
    457.94 Billion USD
    World Rank (Jan-01-2021)
    14
    Market Cap (Jan-01-2021)
    414.31 Billion USD
    Employee Count
    155,800
    Employee Count as of Date
    As on Jan-2023
    Total Assets in USD
    187,380 Million USD
    Total Liabilities in USD
    110,570 Million USD
    Balance Sheet for Period Ending
    Dec-2022 ending year
    Annual Revenue in USD
    94,940 Million USD
    Annual Operating Income in USD
    23,700 Million USD
    Annual Net Income in USD
    17,940.00 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    CEO
    Joaquin Duato
    Chairman
    William C. Weldon
    Stock Exchange LC
    NYSE
    Stock Category LC
    Dow Jones Index (DJIA)
    S&P 500
    Wikipedia
    Yahoo @ NYSE
    Company Profile

    Johnson & Johnson manufactures Consumer Goods, Medical Devices and Equipment and Pharmaceutical Products. As on 2023, Johnson & Johnson has 155,800 employees across 60 countries. Headquarters is in USA.

    As on December-2021, The Company’s subsidiaries operate 85 manufacturing facilities occupying approximately 15.0 million square feet of floor space for managing consumer goods, medical devices and pharmaceutical business segments.

    Facts About Company
    • Johnson & Johnson annual revenue generated for period ending Dec-2022 was 94.94 Billion USD and annual net income was 17.94 Billion USD.
    • Johnson & Johnson annual revenue generated for period ending Dec-2021 was 93.77 Billion USD and annual net income was 20.87 Billion USD.

    Johnson & Johnson annual sales by segment wise for period ending in Dec-2022:

  3. Eli Lilly and Company

    World Rank (Jul-30-2023)
    16
    Market Cap (Jul-30-2023)
    435.220 Billion USD
    World Rank (Dec-25-2022)
    19
    Market Cap (Dec-25-2022)
    349.570 Billion USD
    World Rank (Jan-07-2022)
    39
    Market Cap (Jan-07-2022)
    248.24 Billion USD
    World Rank (Jan-01-2021)
    69
    Market Cap (Jan-01-2021)
    161.51 Billion USD
    Employee Count
    39,000
    Employee Count as of Date
    As on 2022
    Total Assets in USD
    49,489 Million USD
    Total Liabilities in USD
    38,714 Million USD
    Balance Sheet for Period Ending
    Dec-2022 ending year
    Annual Revenue in USD
    28,541 Million USD
    Annual Operating Income in USD
    8,280 Million USD
    Annual Net Income in USD
    6,244.00 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    CEO
    David A. Ricks
    Chairman
    Juan R. Luciano
    Stock Exchange LC
    NYSE
    Bovespa Brazil
    Switzerland
    EURONEXT
    Stock Category LC
    S&P 500
    Wikipedia
    Yahoo @ NYSE
    Company Profile

    Eli Lilly is a healthcare and pharmaceutical company and is USA based MNC company. Key business areas are Oncology, Bio-Medicines, Diabetes and also Animals Health. Headquarters is in USA.

    Facts About Lilly as on 2022:

    • Approximately 39,000 employees worldwide
    • Clinical research conducted in more than 55 countries
    • Research and development facilities located in 8 countries
    • Manufacturing plants located in 8 countries
    • Products marketed in 120 countries
    Facts About Company

    As on 2022, Eli Lilly has 39,000 employees.

    Eli Lilly annual revenue generated for period ending Dec-2022 was 28,541 million USD.

    Eli Lilly annual net income generated for period ending Dec-2022 was 6,244 million USD.

    Eli Lilly annual revenue generated for period ending Dec-2021 was 28,318 million USD.

    Eli Lilly annual net income generated for period ending Dec-2021 was 5,581 million USD.

  4. Procter & Gamble Company

    World Rank (Jul-30-2023)
    23
    Market Cap (Jul-30-2023)
    368.650 Billion USD
    World Rank (Dec-25-2022)
    18
    Market Cap (Dec-25-2022)
    361.660 Billion USD
    World Rank (Jan-07-2022)
    21
    Market Cap (Jan-07-2022)
    393.82 Billion USD
    World Rank (Jan-01-2021)
    19
    Market Cap (Jan-01-2021)
    345.01 Billion USD
    Employee Count
    106,000
    Employee Count as of Date
    As on 2022
    Total Assets in USD
    117,210 Million USD
    Total Liabilities in USD
    70,354 Million USD
    Balance Sheet for Period Ending
    Jun-2022 ending year
    Annual Revenue in USD
    80,180 Million USD
    Annual Operating Income in USD
    17,810 Million USD
    Annual Net Income in USD
    14,460.00 Million USD
    Annual Results for Period Ending
    Jun-2022 ending year
    CEO
    Jon R. Moeller
    Stock Exchange LC
    NYSE
    EURONEXT
    Stock Category LC
    Dow Jones Index (DJIA)
    S&P 500
    Wikipedia
    Yahoo @ NYSE
    Company Profile

    Procter & Gamble Company is one of World's top FMCG Company with Baby Care, Fabric Care, Family Care, Feminine Care, Hair Care, Home Care, Grooming, Personal Health Care, Oral Care, Skin and Personal Care Products. Headquarters is in USA.

    Facts About Company

    As on 2022, Procter & Gamble Company has 106,000 employees.

    Procter & Gamble Company annual net sales for year ending June-2022 was 80.2 billion USD and annual net sales for year ending June-2021 was 76.1 billion USD.

    Procter & Gamble Company annual operating income for year ending June-2022 was 17.8 billion USD and annual operating income for year ending June-2021 was 18 billion USD.

  5. Novo Nordisk A/S

    World Rank (Jul-30-2023)
    24
    Market Cap (Jul-30-2023)
    356.920 Billion USD
    World Rank (Dec-25-2022)
    27
    Market Cap (Dec-25-2022)
    301.520 Billion USD
    World Rank (Jan-07-2022)
    50
    Market Cap (Jan-07-2022)
    231.35 Billion USD
    World Rank (Jan-01-2021)
    66
    Market Cap (Jan-01-2021)
    163.07 Billion USD
    Employee Count
    55,185
    Employee Count as of Date
    As on 2022
    Total Assets in USD
    35,662 Million USD
    Total Liabilities in USD
    23,321 Million USD
    Balance Sheet for Period Ending
    Dec-2022 ending year
    Annual Revenue in USD
    26,157 Million USD
    Annual Operating Income in USD
    11,058 Million USD
    Annual Net Income in USD
    8,208.00 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    CEO
    Lars Fruergaard Jorgensen
    Chairman
    Helge Lund
    Stock Exchange LC
    NYSE
    Stock Category LC
    S&P EUROPE 350
    Wikipedia
    Yahoo @ NYSE
    Company Profile

    Novo Nordisk is Denmark based Multinational Pharmaceutical Company. Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Headquarters is in Denmark.

    Novo Nordisk employs approximately 55,185 employees in 79 countries as on 2022 and markets its products in more than 170 countries.

    Facts About Company

    For year ending December-2022, Novo Nordisk Annual Revenue was 176,954 Million DKK and Net Income was 55,525 Million DKK.

    For year ending December-2021, Novo Nordisk Annual Revenue was 140,800 Million DKK and Net Income was 47,757 Million DKK.

  6. Merck & Co

    World Rank (Jul-30-2023)
    32
    Market Cap (Jul-30-2023)
    269.830 Billion USD
    World Rank (Dec-25-2022)
    30
    Market Cap (Dec-25-2022)
    283.610 Billion USD
    World Rank (Jan-07-2022)
    59
    Market Cap (Jan-07-2022)
    202.83 Billion USD
    World Rank (Jan-01-2021)
    42
    Market Cap (Jan-01-2021)
    206.96 Billion USD
    Employee Count
    69,000
    Employee Count as of Date
    As on 2022
    Total Assets in USD
    109,160 Million USD
    Total Liabilities in USD
    63,102 Million USD
    Balance Sheet for Period Ending
    Dec-2022 ending year
    Annual Revenue in USD
    59,280 Million USD
    Annual Operating Income in USD
    18,280 Million USD
    Annual Net Income in USD
    14,510.00 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    CEO
    Robert M. Davis
    Chairman
    Kenneth C. Frazier
    Stock Exchange LC
    NYSE
    EURONEXT
    Stock Category LC
    Dow Jones Index (DJIA)
    S&P 500
    S&P EUROPE 350
    Wikipedia
    Yahoo @ NYSE
    Company Profile

    Merck & Co is USA based healthcare and pharmaceutical multi-national company. Merck Company manufacture and sells innovative medicines, vaccines, and animal health products. Headquarters is in USA. 

    Merck & Co focus on scientific innovation to deliver medicines and vaccines.

    Facts About Company

    As on 2022, Merck & Co has 69,000 employees.

    For year ending Dec-2022, Merck & Co annual revenue was 59.28 billion USD and annual net income was 14.51 billion USD.

    For year ending Dec-2021, Merck & Co annual revenue was 48.70 million USD and annual net income was 13.04 million USD.

    Total Assets as on Dec-2022 was 109,160 Million USD.

  7. Abbvie

    World Rank (Jul-30-2023)
    33
    Market Cap (Jul-30-2023)
    266.140 Billion USD
    World Rank (Dec-25-2022)
    29
    Market Cap (Dec-25-2022)
    288.440 Billion USD
    World Rank (Jan-07-2022)
    46
    Market Cap (Jan-07-2022)
    238.45 Billion USD
    World Rank (Jan-01-2021)
    51
    Market Cap (Jan-01-2021)
    189.10 Billion USD
    Employee Count
    50,000
    Employee Count as of Date
    As on Jan-2023
    Total Assets in USD
    138,800 Million USD
    Total Liabilities in USD
    121,520 Million USD
    Balance Sheet for Period Ending
    Dec-2022 ending year
    Annual Revenue in USD
    58,054 Million USD
    Annual Operating Income in USD
    18,814 Million USD
    Annual Net Income in USD
    11,782.00 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    CEO
    Richard A. Gonzalez
    Stock Exchange LC
    NYSE
    Stock Category LC
    S&P 500
    Wikipedia
    Yahoo @ NYSE
    Company Profile

    Abbvie is USA based healthcare and pharmaceutical multi-national company. AbbVie is highly focus research-driven bio-pharmaceutical company. Headquarters is in USA.

    Facts About Company

    As on 2023, Abbvie has 50,000 employees.

    Abbvie annual revenue generated for period ending Dec-2022 was 58,054  million USD.

    Abbvie annual net income generated for period ending Dec-2022 was 11,782 million USD.

    Abbvie  annual revenue generated for period ending Dec-2021 was 56,197 million USD.

    Abbvie annual net income generated for period ending Dec-2021 was 11,542 million USD.

    Total Assets as on Dec-2022 was 138,805 Million USD.

  8. Roche Holding AG

    World Rank (Jul-30-2023)
    38
    Market Cap (Jul-30-2023)
    249.730 Billion USD
    World Rank (Dec-25-2022)
    32
    Market Cap (Dec-25-2022)
    261.410 Billion USD
    World Rank (Jan-07-2022)
    25
    Market Cap (Jan-07-2022)
    356.15 Billion USD
    World Rank (Jan-01-2021)
    25
    Market Cap (Jan-01-2021)
    295.78 Billion USD
    Employee Count
    103,613
    Employee Count as of Date
    As on 2022
    Total Assets in USD
    101,260 Million USD
    Total Liabilities in USD
    73,484 Million USD
    Balance Sheet for Period Ending
    Dec-2022 ending year
    Annual Revenue in USD
    72,691 Million USD
    Annual Operating Income in USD
    20,068 Million USD
    Annual Net Income in USD
    14,267.00 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    CEO
    Severin Schwan
    Chairman
    Christoph Franz
    Stock Exchange LC
    Switzerland
    Stock Category LC
    S&P EUROPE 350
    Wikipedia
    Yahoo @ Switzerland
    Company Profile

    Roche Holding is a pioneer in Healthcare Company with headquarters in Basel, Switzerland. Over half of the compounds in Roche Company products pipeline are biopharmaceuticals, enabling them to deliver better-targeted therapies. They are specialized in Oncology, Neuroscience, Infectious Diseases, Immunology, Cardiovascular and Metabolism, Opthamology and Respiratory branches Medicines.

    Facts About Company

    Roche Holding annual revenues for year ending December 2022 was 63.28 billion CHF. (Previous year : 62.8 billion CHF)

    Roche Holding annual operating profit for year ending December 2022 is 17.47 billion CHF. (Previous year : 18.15 billion CHF)

    As on December 2022, Roche Holding has 103,613 employees, 29 research and development sites in Pharmaceuticals and Diagnostics worldwide, 23 manufacturing sites in Pharmaceuticals and Diagnostics worldwide.

  9. AstraZeneca

    World Rank (Jul-30-2023)
    44
    Market Cap (Jul-30-2023)
    221.350 Billion USD
    World Rank (Dec-25-2022)
    40
    Market Cap (Dec-25-2022)
    210.670 Billion USD
    World Rank (Jan-07-2022)
    71
    Market Cap (Jan-07-2022)
    178.12 Billion USD
    World Rank (Jan-01-2021)
    93
    Market Cap (Jan-01-2021)
    130.99 Billion USD
    Employee Count
    83,500
    Employee Count as of Date
    As on 2022
    Total Assets in USD
    96,483 Million USD
    Total Liabilities in USD
    59,425 Million USD
    Balance Sheet for Period Ending
    Dec-2022 ending year
    Annual Revenue in USD
    44,351 Million USD
    Annual Operating Income in USD
    4,561 Million USD
    Annual Net Income in USD
    3,288.00 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    CEO
    Pascal Soriot
    Chairman
    Leif Johansson
    Stock Exchange LC
    NYSE
    Stockholm
    LSE
    Stock Category LC
    Nasdaq 100
    FTSE 100
    S&P EUROPE 350
    UK ADRs
    Wikipedia
    Yahoo @ NYSE
    Company Profile

    AstraZeneca is UK Based Pharmaceutical and Bio-Technology Company. They have done some advanced research on Oncology. In the fight against COVID-19, Astrazeneca is one among World Top 5 Companies which has done advanced phase of Covid-19 testing in collaboration with the University of Oxford and are launching Phase III trials. Headquarters is in UK.

    AstraZeneca Product Sales split by Disease Area for year ending Dec-2021

    Facts About Company

    AstraZeneca annual revenue was 44,351 million USD for year ending Dec-2022 and annual operating profit was 3,757 million USD and annual net income was 3,288 million USD for year ending Dec-2022.

    AstraZeneca has 83,500 employees as on 2022 when compared to with 76,100 employees as on 2020 and 70,600 employees as on 2019.

    AstraZeneca has total assets of 96,483 million USD as on Dec-2022 when compared to 66,729 million USD as on Dec-2020.

  10. Novartis AG

    World Rank (Jul-30-2023)
    45
    Market Cap (Jul-30-2023)
    220.820 Billion USD
    World Rank (Dec-25-2022)
    47
    Market Cap (Dec-25-2022)
    195.460 Billion USD
    World Rank (Jan-07-2022)
    61
    Market Cap (Jan-07-2022)
    201.26 Billion USD
    World Rank (Jan-01-2021)
    39
    Market Cap (Jan-01-2021)
    217.77 Billion USD
    Employee Count
    101,703
    Employee Count as of Date
    As on 2022
    Total Assets in USD
    117,450 Million USD
    Total Liabilities in USD
    58,030 Million USD
    Balance Sheet for Period Ending
    Dec-2022 ending year
    Annual Revenue in USD
    51,830 Million USD
    Annual Operating Income in USD
    9,190 Million USD
    Annual Net Income in USD
    6,950.00 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    CEO
    Vasant Narasimhan
    Chairman
    Joerg Reinhardt
    Stock Exchange LC
    NYSE
    Switzerland
    Stock Category LC
    S&P EUROPE 350
    Wikipedia
    Yahoo @ NYSE
    Company Profile

    Novartis is Switzerland based Multi-National Healthcare and Pharmaceutical company. Novartis Company focus on patented medicines, generic medicines and eye care – segments where they have the innovation power and global scale necessary to compete effectively. At the same time, Novartis is expanding their presence in the emerging markets of Asia, Africa and Latin America, where there is fast-growing demand for access to high- quality medicines and healthcare.

    Facts About Company

    Novartis annual revenue was 51.83 billion USD for year ending Dec-2022 and annual operating profit was 9.19 billion USD and annual net income was 6.95 billion USD for the same period.

    Novartis had over 101,703 employees worldwide as on 2022.

    Split of Novartis annual revenue 50,545 billion USD for year ending Dec-2022, Innovative Medicines business segment earned 41,296 million USD revenue and Sandoz business segment earned 9,249 million USD revenue.